These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15755505)

  • 1. Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo.
    Lewis KA; Holstein SA; Hohl RJ
    Leuk Res; 2005 May; 29(5):527-33. PubMed ID: 15755505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
    Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
    Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
    Müller-Tidow C; Kiehl M; Sindermann JR; Probst M; Banger N; Zühlsdorf M; Chou TC; Berdel WE; Serve H; Koch OM
    Int J Oncol; 2003 Jul; 23(1):151-8. PubMed ID: 12792788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A.
    Wang W; Macaulay RJ
    Int J Cancer; 1999 Jul; 82(3):430-4. PubMed ID: 10399961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway.
    Haney SL; Varney ML; Chhonker Y; Talmon G; Smith LM; Murry DJ; Holstein SA
    Pharmacol Res; 2021 May; 167():105528. PubMed ID: 33667685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the cholesterol pathway and Ras maturation in response to stress.
    Shack S; Gorospe M; Fawcett TW; Hudgins WR; Holbrook NJ
    Oncogene; 1999 Oct; 18(44):6021-8. PubMed ID: 10557091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
    Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial silencing of a hydroxy-methylglutaryl-CoA reductase-encoding gene in Trichoderma harzianum CECT 2413 results in a lower level of resistance to lovastatin and lower antifungal activity.
    Cardoza RE; Hermosa MR; Vizcaíno JA; González F; Llobell A; Monte E; Gutiérrez S
    Fungal Genet Biol; 2007 Apr; 44(4):269-83. PubMed ID: 17218128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.
    Laezza C; Mazziotti G; Fiorentino L; Gazzerro P; Portella G; Gerbasio D; Carella C; Matarese G; Bifulco M
    J Mol Med (Berl); 2006 Nov; 84(11):967-73. PubMed ID: 16947002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.
    Wu J; Wong WW; Khosravi F; Minden MD; Penn LZ
    Cancer Res; 2004 Sep; 64(18):6461-8. PubMed ID: 15374955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
    Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
    Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies.
    Holstein SA; Knapp HR; Clamon GH; Murry DJ; Hohl RJ
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):155-64. PubMed ID: 16133537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ
    Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia.
    Minden MD; Dimitroulakos J; Nohynek D; Penn LZ
    Leuk Lymphoma; 2001 Feb; 40(5-6):659-62. PubMed ID: 11426537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis (review).
    Rao KN
    Anticancer Res; 1995; 15(2):309-14. PubMed ID: 7762999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.